Skip to main content
Equibles
OMCL logo

OMCL · Omnicell, Inc. · Metrics

Track OMCL — free

Use OMCL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OMCL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$36.65 -0.23 (-0.62%) At close · Oct 30 Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.67B
Shares
45.61M
Volume · Oct 30 785.6K Avg daily vol (3M) 605.34K

OMCL metrics

110 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$36.65
Market cap
$1.67B

Price action

20 metrics
Price change (1W)
-2.9%
Price change (30D)
+9.6%
Price change (3M)
+3.6%
Price change (6M)
-14.4%
Price change (YTD)
-19.1%
Price change (1Y)
+9.1%
Trailing year
Price change (5Y)
-79.4%
52-week high
$51.39
52-week low
$32.23
Change from 52-week high
-28.7%
Change from 52-week low
+13.7%
Annualized volatility
48.6%
Annualized volatility (3M)
34.5%
Beta
1.1
RSI (14D)
55.5
Price vs SMA 50
+5.9%
Price vs SMA 200
-6.1%
Avg volume (3M)
605,340
Relative volume
1.3
Average dollar volume
$21.33M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
45.61M

Valuation

12 metrics
P / E (TTM)
43.6
Trailing earnings · reciprocal yield 2.3%
PEG ratio
0.1
EV / revenue
1.2×
reciprocal yield 80.0%
EV / EBITDA
11.6×
reciprocal yield 8.6%
EV / EBIT
26.9×
reciprocal yield 3.7%
P / sales
1.3×
reciprocal yield 74.1%
P / book
1.3
reciprocal yield 76.8%
FCF yield
8.5%
TTM · current market cap
Buyback yield
3.7%
P / FCF
11.8
reciprocal yield 8.5%
P / operating cash flow
9.3
reciprocal yield 10.8%
Earnings yield
2.3%

Historical valuation

8 metrics
P / E historical average (3Y)
219.0×
reciprocal yield 0.5%
P / E historical average (5Y)
180.0×
reciprocal yield 0.6%
EV / revenue historical average (3Y)
1.4×
reciprocal yield 69.8%
EV / revenue historical average (5Y)
2.6×
reciprocal yield 39.1%
EV / EBIT historical average (3Y)
855.3×
reciprocal yield 0.1%
EV / EBIT historical average (5Y)
494.2×
reciprocal yield 0.2%
EV / EBITDA historical average (3Y)
25.0×
reciprocal yield 4.0%
EV / EBITDA historical average (5Y)
32.2×
reciprocal yield 3.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-29

Profitability

9 metrics
Gross margin
44.8%
Operating margin
4.6%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
$558.13M
Operating profit (TTM)
$57.96M
Net income (TTM)
$39.08M
Trailing 12 months
Diluted EPS (TTM)
$0.84
FCF margin
11.4%
Effective tax rate
36.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$27.08
Gross profit per diluted share (TTM)
$12.12
Operating profit per diluted share (TTM)
$1.26
EBITDA per diluted share (TTM)
$2.92
Net income per diluted share (TTM)
$0.85
Operating cash flow per diluted share (TTM)
$3.94
Free cash flow per diluted share (TTM)
$3.09
Capital expenditures per diluted share (TTM)
$0.84
R&D per diluted share (TTM)
$1.92
Stock compensation per diluted share (TTM)
$0.98
Book value per share
$27.36

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
+330.7%
Revenue (TTM)
$1.25B
Trailing 12 months
EPS growth YoY
+333.3%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.9%
Revenue CAGR (5Y)
+5.8%
EPS CAGR (3Y)
-30.7%
EPS CAGR (5Y)
-44.2%
FCF CAGR (3Y)
+42.2%
FCF CAGR (5Y)
-11.8%

Quality

14 metrics
Return on equity
3.0%
Return on assets
2.0%
Debt / equity
0.1
Current ratio
1.6
EBITDA (TTM)
$134.53M
Free cash flow (TTM)
$142.60M
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
-0.9
Return on invested capital
3.2%
Trailing 12 months
Net cash
$123.96M
Latest balance sheet
Cash & equivalents
$292.17M
Total assets
$2.00B
Total debt
$168.20M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$181.44M
Capital expenditures (TTM)
$38.84M
R&D (TTM)
$88.39M
SG&A (TTM)
$411.77M
Stock compensation (TTM)
$44.89M
R&D / revenue
7.1%
Stock compensation / revenue
3.6%

Ownership (13F)

9 metrics
13F filers
311
13F filer change QoQ
+35
Institutional ownership
106.1%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.3%
Holder tenure
13.3
Price vs estimated holder cost
+6.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
30.2%

Short interest

3 metrics
Short interest
7.2%
Latest settlement · 7.5 days to cover
Days to cover
7.5d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$113,609
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 926326 CUSIP 68213N109 13F (30d) 75 filings 67 filers Visit website Investor relations